STAT3 and prostate carcinoma: Previous studies showed that cryptotanshinone has antibacterial activity (Lee et al., 1999), inhibits angiogenesis (Hur et al., 2005) and inhibits STAT3 in prostate cancer (Shin et al., 2009).